Dexamethasone in Tick-borne Encephalitis
ConditionTick-Borne Encephalitis
Trial statusRecruiting
Trial phasePhase 3
Trial typeInterventional
Biological sexAll
Age18+
SponsorUniversity Medical Centre Ljubljana
About this trial
The purpose of this study is to investigate the efficacy of dexamethasone in patients with tick-borne encephalitis.
Eligibility criteria
Qualifiers
age 18 years or older and
clinical signs and symptoms of meningoencephalitis or meningomyelitis and
cerebrospinal pleocytosis and
serological confirfmation of tick-borne encephalitis virus infection
Disqualifiers
pregnancy or
severe neurological impairment befor tick-borne encephalitis or
systemic corticosteroid treatment in the past 30 days or
allergy to corticosteroids or
Trial design
Treatments tested in this trial
- Dexametasone
- Saline (0.9% NaCl)
Treatment groups
200 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov